Search
for
Sort by
Research 181–210 of 1000+
- Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension
- Transsexualism
- NEW PROPRIETARY BRANDS: Gabapentin
- NEW PROPRIETARY BRANDS: Cephalexin
- NEW FORMULATIONS: Sodium cromoglycate
- Endocrinology of Transgender Medicine
- Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- How to diagnose a lipodystrophy syndrome
- Obesity and the Polycystic Ovary Syndrome
- Male hormonal contraception: looking back and moving forward
- Female pattern hair loss
- Efficacy and Safety of SER120 Nasal Spray in Patients with Nocturia: Pooled Analysis of 2 Randomized, Double-Blind, Placebo Controlled, Phase 3 Trials
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Transgender and Migraine
- Menopause
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Effects of 5-alpha reductase inhibitors
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection
- Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)
- Recommendations on trichological treatments during COVID-19 pandemic